Morningstar Investor users sign in here.

Chongqing Genrix Biopharmaceutical Co Ltd

688443

Company Profile

  • Business description

    Chongqing Genrix Biopharmaceutical Co Ltd is engaged in the research & development, production and sales of antibody drugs. The company has a total of more than ten products under research covering three major therapeutic areas. The progress of core products is leading, and some product pipelines are as follows; autoimmune disease, infectious disease, and tumor. Its product Xeligekimab injection (Xeligekimab) is a recombinant fully human anti-IL-17A monoclonal antibody independently developed by the company, which has been accepted by the National Medical Products Administration (NMPA) for new drug marketing applications.

  • Contact

    No. 699, Maliu Avenue
    Area A, Building 2
    International Bio City
    Banan
    Chongqing 401338
    CHN

    T: +86 2361758666

    http://www.genrixbio.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2024

    Employees

    547

Stocks News & Analysis

stocks

The secrets of Australia’s Berkshire Hathaway

Washington H. Soul Pattinson is an ASX top 50 stock with one of the best investment track records this country has seen. Yet, most Australians haven’t heard of it, and the company seems to prefer it that way.
stocks

Have some of the ASX 200's worst performers fallen too far?

These four stocks have had an awful twelve months. Morningstar's analysts weigh in on whether they offer good value yet. 
stocks

Private equity bid dramatically undervalues ASX listed share

We believe the bid is an attempt to capitalise on share price weakness. 

Markets

Index
Last price
Change
% Change
All Ordinaries 8,002.50 39.40 0.49%
CAC 40 7,708.02 156.68 -1.99%
DAX 40 18,265.68 365.18 -1.96%
Dow JONES (US) 38,608.02 104.19 -0.27%
FTSE 100 8,163.67 51.81 -0.63%
HKSE 18,112.63 174.79 0.97%
NASDAQ 17,648.00 39.57 0.22%
Nikkei 225 38,720.47 156.24 -0.40%
NZX 50 Index 11,872.64 130.76 1.11%
S&P 500 5,426.34 5.31 0.10%
S&P/ASX 200 7,749.70 34.20 0.44%
SSE Composite Index 3,028.92 8.55 -0.28%

Market Movers

Name
Last price
Change
% Change
Sigma Healthcare Ltd SIG 1.16 0.05 -3.73%
Peninsula Energy Ltd PEN 0.10 0.00 4.17%
South32 Ltd S32 3.64 0.00 0.00%
Pilbara Minerals Ltd PLS 3.32 0.09 -2.64%
Telstra Group Ltd TLS 3.53 0.01 0.28%
Core Lithium Ltd CXO 0.09 0.00 -1.05%
Red 5 Ltd RED 0.44 0.01 1.15%
Mirvac Group MGR 1.93 0.03 1.58%
TerraCom Ltd TER 0.22 0.01 -2.27%
Imugene Ltd IMU 0.06 0.00 1.75%